Schwab Andrew J. — SEC insider filings

SEC reporting owner CIK 1598549. 73 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers the 50 most recent of 73 filings on record, filed 2022-05-25 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Enliven Therapeutics, Inc. (ELVN)10% owner6—8 legs · 1,962,500 sh · $29,795,0003
CinCor Pharma, Inc. (CINC)10% owner22 legs · 600,000 sh · $18,000,000—3
Camp4 Therapeutics Corp (CAMP)Director81 leg · 909,090 sh · $9,999,9905 legs · 591,875 sh · $2,495,76410
Artiva Biotherapeutics, Inc. (ARTV)10% owner11 leg · 833,333 sh · $9,999,996—5
Pear Therapeutics, Inc. (PEAR)10% owner6—33 legs · 18,431,771 sh · $5,712,873—
Entrada Therapeutics, Inc. (TRDA)10% owner5—13 legs · 531,285 sh · $4,068,043—
Rallybio Corp (RLYB)10% owner3—5 legs · 350,000 sh · $3,995,000—
scPharmaceuticals Inc. (SCPH)10% owner2—12 legs · 826,622 sh · $3,585,860—
Skye Bioscience, Inc. (SKYE)Director, 10% owner15—25 legs · 1,055,553 sh · $2,995,50315
Latigo Biotherapeutics, Inc. (LTGO)10% owner1——6

+1 more issuer among the filings shown — every filing appears in the table below.

Insider filings — Schwab Andrew J.

FiledFormIssuerReported transactionsSource
2026-09-244Skye Bioscience, Inc. (SKYE)Sale (S): 27,612 @ $1.65 · Sale (S): 1,088 @ $1.65 · Sale (S): 114,851 @ $1.61 · Sale (S): 4,528 @ $1.61EDGAR
2026-09-184Skye Bioscience, Inc. (SKYE)Sale (S): 32,607 @ $1.91 · Sale (S): 1,285 @ $1.91EDGAR
2026-08-314Camp4 Therapeutics Corp (CAMP)Sale (S): 400,000 @ $4.04EDGAR
2026-08-264Camp4 Therapeutics Corp (CAMP)Sale (S): 10 @ $4.50EDGAR
2026-08-214Camp4 Therapeutics Corp (CAMP)Sale (S): 45,147 @ $4.76 · Sale (S): 114,700 @ $4.54 · Sale (S): 32,018 @ $4.50EDGAR
2026-08-204Skye Bioscience, Inc. (SKYE)Sale (S): 45,090 @ $0.38 · Sale (S): 1,830 @ $0.38 · Sale (S): 253,080 @ $0.38 · Sale (S): 10,255 @ $0.35 · Sale (S): 409 @ $0.35 · Sale (S): 57,476 @ $0.35 · +3 moreEDGAR
2026-08-124Latigo Biotherapeutics, Inc. (LTGO)
jointly with 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities II, L.P., 5AM Opportunities II (GP), LLC, PARMAR KUSH
Conversion (C): 4,975,543 · Conversion (C): 2,350,419 · Conversion (C): 3,152,305 (derivative) @ $0 · Conversion (C): 1,823,238 (derivative) @ $0 · Conversion (C): 866,018 (derivative) @ $0 · Conversion (C): 1,484,401 (derivative) @ $0EDGAR
2026-08-104Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M
Sale (S): 10,494 @ $7 · Sale (S): 52,317 @ $6.85EDGAR
2026-08-054Camp4 Therapeutics Corp (CAMP)Grant/award (A): 3,179,558 (derivative) @ $1.53EDGAR
2026-08-034Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M
Sale (S): 114,756 @ $6.93 · Sale (S): 1,718 @ $6.85EDGAR
2026-06-124Camp4 Therapeutics Corp (CAMP)Grant/award (A): 28,000 (derivative) @ $0EDGAR
2026-04-024Skye Bioscience, Inc. (SKYE)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2026-02-094Skye Bioscience, Inc. (SKYE)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2025-11-184Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M
Sale (S): 200,000 @ $8.80EDGAR
2025-09-154Camp4 Therapeutics Corp (CAMP)Grant/award (A): 2,941,176 @ $1.53EDGAR
2025-08-224Skye Bioscience, Inc. (SKYE)Sale (S): 58,642 @ $3.57 · Sale (S): 2,314 @ $3.57 · Sale (S): 163,979 @ $3.42 · Sale (S): 6,470 @ $3.42EDGAR
2025-07-114Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M
Sale (S): 20,065 @ $7.50 · Sale (S): 6,935 @ $7.50EDGAR
2025-07-014Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M
Sale (S): 55,735 @ $6.91 · Sale (S): 19,265 @ $6.91 · Sale (S): 18,578 @ $6.81 · Sale (S): 6,422 @ $6.81 · Sale (S): 18,578 @ $7.12 · Sale (S): 6,422 @ $7.12EDGAR
2025-06-274Camp4 Therapeutics Corp (CAMP)Grant/award (A): 9,000 (derivative) @ $0EDGAR
2025-02-264Skye Bioscience, Inc. (SKYE)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-10-304Skye Bioscience, Inc. (SKYE)Grant/award (A): 70,000 (derivative) @ $0EDGAR
2024-10-154Camp4 Therapeutics Corp (CAMP)Conversion (C): 1,337,592 · Conversion (C): 378,463 · Conversion (C): 302,770 · Purchase (P): 909,090 @ $11 · Conversion (C): 15,002,166 (derivative) · Conversion (C): 4,244,770 (derivative) · +1 moreEDGAR
2024-09-134Skye Bioscience, Inc. (SKYE)Sale (S): 214,556 @ $6.60 · Sale (S): 36,504 @ $6.60 · Sale (S): 1,440 @ $6.60 · Sale (S): 11,758 @ $6.06 · Sale (S): 2,000 @ $6.06 · Sale (S): 79 @ $6.06EDGAR
2024-07-244Artiva Biotherapeutics, Inc. (ARTV)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P., PARMAR KUSH
Conversion (C): 1,058,284 · Other (J): 112,966 @ $10.20 · Other (J): 348,721 @ $10.20 · Purchase (P): 833,333 @ $12 · Conversion (C): 843,592 (derivative) · Conversion (C): 214,692 (derivative)EDGAR
2024-03-154Skye Bioscience, Inc. (SKYE)Grant/award (A): 450,000 @ $10EDGAR
2024-03-044Skye Bioscience, Inc. (SKYE)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-02-164Enliven Therapeutics, Inc. (ELVN)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., PARMAR KUSH
Sale (S): 688,358 @ $14.90 · Sale (S): 136,642 @ $14.90EDGAR
2024-02-024Skye Bioscience, Inc. (SKYE)Grant/award (A): 5,206,074 @ $2.31EDGAR
2024-02-024Enliven Therapeutics, Inc. (ELVN)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., PARMAR KUSH
Sale (S): 417,187 @ $15 · Sale (S): 82,813 @ $15EDGAR
2023-11-064Skye Bioscience, Inc. (SKYE)Grant/award (A): 14,110 (derivative) @ $0EDGAR
2023-09-284Enliven Therapeutics, Inc. (ELVN)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., PARMAR KUSH
Sale (S): 164,789 @ $15 · Sale (S): 32,711 @ $15EDGAR
2023-08-294Skye Bioscience, Inc. (SKYE)Grant/award (A): 1,472,692 (derivative) @ $0EDGAR
2023-08-284Enliven Therapeutics, Inc. (ELVN)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., PARMAR KUSH
Sale (S): 367,124 @ $16 · Sale (S): 72,876 @ $16EDGAR
2023-08-224Skye Bioscience, Inc. (SKYE)Grant/award (A): 267,602,039 · Grant/award (A): 10,558,878 · Grant/award (A): 684,361,447 @ $0.01 · Grant/award (A): 161,944,872 @ $0.01 · Grant/award (A): 6,389,921 @ $0.01 · Grant/award (A): 426,348,120 (derivative) @ $0EDGAR
2023-04-124Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 12,836,489 @ $0.12 · Sale (S): 534,855 @ $0.12 · Sale (S): 3,172,769 @ $0.12EDGAR
2023-04-064Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 27,567 (derivative) @ $0EDGAR
2023-03-094Rallybio Corp (RLYB)
jointly with 5AM Partners V, LLC, 5AM Ventures V, L.P., ROCKLAGE SCOTT M
Sale (S): 100,000 @ $8.20EDGAR
2023-02-284CinCor Pharma, Inc. (CINC)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I, L.P., PARMAR KUSH, 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P., 5AM Opportunities I (GP), LLC
Code (U): 3,953,990 · Code (U): 487,333 · Code (U): 496,323EDGAR
2023-02-274Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 4,838,092 · Grant/award (A): 960,383EDGAR
2022-12-024Akouos, Inc. (AKUS)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M
Code (U): 3,153,333 · Code (U): 982,453EDGAR
2022-11-154Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 28,205 @ $3.19 · Sale (S): 1,175 @ $3.19 · Sale (S): 11,643 @ $2.79 · Sale (S): 485 @ $2.79 · Sale (S): 61,222 @ $2.52 · Sale (S): 2,551 @ $2.52EDGAR
2022-11-024Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 40,477 @ $2.78 · Sale (S): 1,687 @ $2.78 · Sale (S): 1,408 @ $2.80 · Sale (S): 59 @ $2.80 · Sale (S): 10,155 @ $2.72 · Sale (S): 423 @ $2.72EDGAR
2022-10-114scPharmaceuticals Inc. (SCPH)
jointly with 5AM Partners IV, LLC, 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Ventures IV, L.P., DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 30,457 @ $5.02 · Sale (S): 1,269 @ $5.02 · Sale (S): 5,808 @ $5.02 · Sale (S): 456,413 @ $4.09 · Sale (S): 19,017 @ $4.09 · Sale (S): 87,036 @ $4.09EDGAR
2022-09-164Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 273,664 @ $1.94 · Sale (S): 11,403 @ $1.94 · Sale (S): 261,840 @ $1.81 · Sale (S): 10,910 @ $1.81 · Sale (S): 337 @ $1.75 · Sale (S): 14 @ $1.75EDGAR
2022-09-084scPharmaceuticals Inc. (SCPH)
jointly with 5AM Partners IV, LLC, 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Ventures IV, L.P., DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 21,702 @ $5.52 · Sale (S): 904 @ $5.52 · Sale (S): 4,016 @ $5.52 · Sale (S): 163,034 @ $4.75 · Sale (S): 6,793 @ $4.75 · Sale (S): 30,173 @ $4.75EDGAR
2022-09-084Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 298,714 @ $2.36 · Sale (S): 12,446 @ $2.36 · Sale (S): 148,337 @ $1.92 · Sale (S): 6,181 @ $1.92 · Sale (S): 292,149 @ $1.81 · Sale (S): 12,173 @ $1.81EDGAR
2022-08-184Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, ROCKLAGE SCOTT M
Sale (S): 160,476 @ $1.78 · Sale (S): 6,686 @ $1.78 · Sale (S): 9,674 @ $1.71 · Sale (S): 403 @ $1.71 · Sale (S): 213,851 @ $1.55 · Sale (S): 8,910 @ $1.55EDGAR
2022-08-174CinCor Pharma, Inc. (CINC)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., PARMAR KUSH, 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P.
Purchase (P): 112,667 @ $30 · Purchase (P): 487,333 @ $30EDGAR
2022-06-074Rallybio Corp (RLYB)
jointly with 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, 5AM Partners V, LLC, 5AM Ventures V, L.P., ROCKLAGE SCOTT M
Sale (S): 50,329 @ $12.50 · Sale (S): 99,671 @ $12.50EDGAR
2022-05-254Rallybio Corp (RLYB)
jointly with 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, 5AM Partners V, LLC, 5AM Ventures V, L.P., ROCKLAGE SCOTT M
Sale (S): 33,553 @ $13 · Sale (S): 66,447 @ $13EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1598549 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs